Cantor Fitzgerald Begins Coverage on AbbVie (NYSE:ABBV)

Cantor Fitzgerald initiated coverage on shares of AbbVie (NYSE:ABBV – Free Report) in a research note released on Friday, MarketBeat.com reports. The brokerage issued an overweight rating and a $200.00 target price on the stock. ABBV has been the topic of several other reports. Guggenheim increased their price target on shares of AbbVie from $188.00 […]

Related Keywords

Venclexta Venclyxto ,Scottt Reents ,William Blair ,Azita Saleki Gerhardt ,Aspen Wealth Strategies ,Arcadia Investment Management Corp ,Spinnaker Investment Group ,Lokken Investment Group ,Cantor Fitzgerald ,Abbvie Company Profile ,Marks Group Wealth Management Inc ,Barclays ,Securities Exchange Commission ,Abbvie Inc ,Free Report ,Moderate Buy ,Vie Trading Down ,Get Free Report ,Exchange Commission ,Investment Group ,Investment Management Corp ,Wealth Strategies ,Group Wealth Management Inc ,Vie Inc ,Abbvie Daily ,